Prostatic Neoplasms - Radiotherapy
Research News and Information

Sunday, November 22, 2009

Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.

13 Nov 2009 PURPOSE: To quantify and evaluate the accumulated prostate, rectum, and bladder dose for several strategies including rotational organ motion correction for intensity-modulated radiotherapy (IMRT) of prostate cancer using realistic organ motion ... Read more...

Validation of temporal optimization effects for a single fraction of radiation in vitro.

13 Nov 2009 PURPOSE: To experimentally validate how temporal modification of the applied dose pattern within a single fraction of radiation therapy affects cell survival. METHOD AND MATERIALS: Using the linear-quadratic model, we have previously demonstrated ... Read more...

Study of robustness of IMPT and IMRT for prostate cancer against organ movement.

30 Oct 2009 PURPOSE: Intensity-modulated radiotherapy with photons (IMRT) and protons (IMPT) produces dose distributions that have high conformality to the planning target volume and sufficient sparing of the organs at risk if calculated on a single static ... Read more...

Latest indexed articles for 'Prostatic Neoplasms - Radiotherapy'

These are the very latest articles for this heading:

• Radiation-induced sequelae measured by means of lymphocyte apoptosis: importance of certain single nucleotide polymorphisms: in regard to Schnarr et al. (Int J Radiat Oncol Biol Phys 2009). 13 Nov 2009
• Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects. 13 Nov 2009
• Validation of temporal optimization effects for a single fraction of radiation in vitro. 13 Nov 2009
• Study of robustness of IMPT and IMRT for prostate cancer against organ movement. 30 Oct 2009
• Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters. 4 Oct 2009
• Helical tomotherapy with simultaneous integrated boost for high-risk and lymph node-positive prostate cancer: early report on acute and late toxicity. 29 Sep 2009
• Megavoltage CT in helical tomotherapy - clinical advantages and limitations of special physical characteristics. 29 Sep 2009
• Editorial comment. 29 Sep 2009
• Image-guided radiotherapy in near real time with intensity-modulated radiotherapy megavoltage treatment beam imaging. 29 Sep 2009
• Physiologic reactions after proton beam therapy in patients with prostate cancer: significance of urinary autoactivation. 29 Sep 2009
• Don't squeeze hypofractionated schedules into too-short overall times. 29 Sep 2009
• Re: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial I. M. Thompson, C. M. Tangen, J. Paradelo, M. S. Lucia, G. Miller, D. Troyer, E. Messing, J. Forman, J. Chin, G. Swanson, E. Canby-Hagino and E. D. Crawford J Urol 2009; 181: 956-962. 16 Sep 2009
• Duration of androgen suppression in prostate cancer. 15 Sep 2009
• Transperitoneal laparoscopic prostatectomy does not increase small bowel within the target volume for postoperative radiotherapy. 14 Sep 2009
• Effect of a prostaglandin--given rectally for prevention of radiation-induced acute proctitis--on late rectal toxicity. Results of a phase III randomized, placebo-controlled, double-blind study. 10 Sep 2009
• Using cone-beam computed tomography to evaluate the impact of bladder filling status on target position in prostate radiotherapy. 10 Sep 2009
• RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study. 7 Sep 2009
• External radiotherapy for prostate cancer with or without androgen deprivation: Geneva, 1991 to 2004. 3 Sep 2009
• External radiotherapy with or without hormonal ablation therapy. 3 Sep 2009
• Radical prostatectomy reigns supreme. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Prostatic Neoplasms'

Definition: Tumors or cancer of the PROSTATE.

Descriptor UI: D011471

Alternative terms: Prostatic Neoplasms; Neoplasms, Prostate; Neoplasm, Prostate; Prostate Neoplasm; Neoplasms, Prostatic; Neoplasm, Prostatic; Prostatic Neoplasm; Prostate Neoplasms; Prostate Cancer; Cancer, Prostate; Cancers, Prostate; Prostate Cancers; Cancer of the Prostate; Prostatic Cancer; Cancer, Prostatic; Cancers, Prostatic; Prostatic Cancers; Cancer of Prostate;

Related Mesh Headings: Prostatic Hyperplasia; Prostate-Specific Antigen;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.945.440.770; C12.294.260.750; C12.294.565.625; C12.758.409.750;

Technical Notes: coordinate IM with histological type of neoplasm (IM); note PROSTATIC ADENOMA see PROSTATIC HYPERPLASIA is also available